Recent Company News

• 07:43 AM ET Nov 06, 2025
  

  Evaxion Biotech reports Q3 EPS $0.01 vs FactSet $0.20 [2 est, ($0.01)-0.40] ($5.66, 0.00)

• 07:30 AM ET Nov 06, 2025
  

  Evaxion announces business update and third quarter 2025 financial results

• 09:11 AM ET Nov 03, 2025
  

  Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate ($5.75, 0.00)

• 09:05 AM ET Oct 31, 2025
  

  Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

• 08:00 AM ET Oct 31, 2025
  

  Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

• 04:54 PM ET Oct 30, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:44 AM ET Oct 30, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:02 AM ET Oct 30, 2025
  

  Evaxion Biotech raises $7.2M, extending cash runway to H2 of 2027

• 10:46 PM ET Oct 29, 2025
  

  Evaxion Biotech initiated buy at Jones ($5.75, 0.00)

• 08:02 AM ET Oct 27, 2025
  

  Evaxion Biotech appoints Dr Helen Tayton-Martin as new CEO ($5.89, 0.00)